nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—Metipranolol—glaucoma	0.237	0.588	CrCtD
Metoprolol—Betaxolol—glaucoma	0.165	0.412	CrCtD
Metoprolol—ADRB2—Metipranolol—glaucoma	0.0274	0.108	CbGbCtD
Metoprolol—ADRB2—Levobunolol—glaucoma	0.0274	0.108	CbGbCtD
Metoprolol—ADRB1—Levobunolol—glaucoma	0.0269	0.107	CbGbCtD
Metoprolol—ADRB1—Metipranolol—glaucoma	0.0269	0.107	CbGbCtD
Metoprolol—ADRB2—Carteolol—glaucoma	0.0233	0.0922	CbGbCtD
Metoprolol—ADRB1—Carteolol—glaucoma	0.0229	0.0908	CbGbCtD
Metoprolol—Acebutolol—Metipranolol—glaucoma	0.0187	0.0695	CrCrCtD
Metoprolol—ADRB2—Dipivefrin—glaucoma	0.0166	0.0657	CbGbCtD
Metoprolol—ADRB2—Betaxolol—glaucoma	0.0157	0.0623	CbGbCtD
Metoprolol—ADRB1—Betaxolol—glaucoma	0.0155	0.0613	CbGbCtD
Metoprolol—Practolol—Metipranolol—glaucoma	0.0154	0.0573	CrCrCtD
Metoprolol—Oxprenolol—Metipranolol—glaucoma	0.0154	0.0573	CrCrCtD
Metoprolol—Alprenolol—Metipranolol—glaucoma	0.0154	0.0573	CrCrCtD
Metoprolol—Chlorphenesin—Betaxolol—glaucoma	0.0154	0.0571	CrCrCtD
Metoprolol—Atenolol—Metipranolol—glaucoma	0.0146	0.0542	CrCrCtD
Metoprolol—Esmolol—Metipranolol—glaucoma	0.0139	0.0515	CrCrCtD
Metoprolol—Pindolol—Levobunolol—glaucoma	0.0139	0.0514	CrCrCtD
Metoprolol—Pindolol—Carteolol—glaucoma	0.0139	0.0514	CrCrCtD
Metoprolol—Pindolol—Metipranolol—glaucoma	0.0132	0.0491	CrCrCtD
Metoprolol—Acebutolol—Betaxolol—glaucoma	0.0131	0.0486	CrCrCtD
Metoprolol—Bisoprolol—Betaxolol—glaucoma	0.0122	0.0453	CrCrCtD
Metoprolol—Alprenolol—Betaxolol—glaucoma	0.0108	0.0401	CrCrCtD
Metoprolol—Oxprenolol—Betaxolol—glaucoma	0.0108	0.0401	CrCrCtD
Metoprolol—Practolol—Betaxolol—glaucoma	0.0108	0.0401	CrCrCtD
Metoprolol—Atenolol—Betaxolol—glaucoma	0.0102	0.0379	CrCrCtD
Metoprolol—ADRB2—Timolol—glaucoma	0.0101	0.0401	CbGbCtD
Metoprolol—ADRB1—Timolol—glaucoma	0.00997	0.0395	CbGbCtD
Metoprolol—Esmolol—Betaxolol—glaucoma	0.00971	0.036	CrCrCtD
Metoprolol—Pindolol—Betaxolol—glaucoma	0.00925	0.0343	CrCrCtD
Metoprolol—Propranolol—Levobunolol—glaucoma	0.00904	0.0335	CrCrCtD
Metoprolol—Propranolol—Carteolol—glaucoma	0.00904	0.0335	CrCrCtD
Metoprolol—Propranolol—Metipranolol—glaucoma	0.00862	0.032	CrCrCtD
Metoprolol—Propranolol—Betaxolol—glaucoma	0.00603	0.0224	CrCrCtD
Metoprolol—CYP2D6—Carteolol—glaucoma	0.00583	0.0231	CbGbCtD
Metoprolol—CYP2D6—Betaxolol—glaucoma	0.00394	0.0156	CbGbCtD
Metoprolol—CYP2C19—Methazolamide—glaucoma	0.00393	0.0156	CbGbCtD
Metoprolol—CYP2C19—Timolol—glaucoma	0.00334	0.0132	CbGbCtD
Metoprolol—CYP2D6—Methazolamide—glaucoma	0.00299	0.0118	CbGbCtD
Metoprolol—ABCB1—Timolol—glaucoma	0.00269	0.0107	CbGbCtD
Metoprolol—CYP2D6—Timolol—glaucoma	0.00254	0.0101	CbGbCtD
Metoprolol—ABCB1—Clonidine—glaucoma	0.00229	0.00908	CbGbCtD
Metoprolol—CYP2D6—Clonidine—glaucoma	0.00216	0.00856	CbGbCtD
Metoprolol—ADRB2—Treprostinil—Latanoprost—glaucoma	0.00073	1	CbGdCrCtD
Metoprolol—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A13—glaucoma	0.000121	0.0527	CbGpPWpGaD
Metoprolol—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—glaucoma	8.85e-05	0.0386	CbGpPWpGaD
Metoprolol—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	8.79e-05	0.0383	CbGpPWpGaD
Metoprolol—SLC22A2—Amine compound SLC transporters—SLC6A13—glaucoma	8.39e-05	0.0366	CbGpPWpGaD
Metoprolol—ADRB1—Endothelin Pathways—MYLK—glaucoma	8.33e-05	0.0363	CbGpPWpGaD
Metoprolol—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	6.86e-05	0.0299	CbGpPWpGaD
Metoprolol—SLC22A2—Neurotransmitter Release Cycle—SLC6A13—glaucoma	6.41e-05	0.0279	CbGpPWpGaD
Metoprolol—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	6.24e-05	0.0272	CbGpPWpGaD
Metoprolol—SLC22A2—Amine compound SLC transporters—SLC6A1—glaucoma	6.14e-05	0.0268	CbGpPWpGaD
Metoprolol—SLC22A2—Neurotransmitter Release Cycle—SLC6A1—glaucoma	4.69e-05	0.0204	CbGpPWpGaD
Metoprolol—ADRB1—Melatonin metabolism and effects—CYP1B1—glaucoma	4.6e-05	0.02	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Other—PTGFR—glaucoma	4.38e-05	0.0191	CbGpPWpGaD
Metoprolol—ADRB1—Melatonin metabolism and effects—EDN1—glaucoma	3.72e-05	0.0162	CbGpPWpGaD
Metoprolol—Pain—Dorzolamide—glaucoma	3.44e-05	0.000469	CcSEcCtD
Metoprolol—Insomnia—Pilocarpine—glaucoma	3.43e-05	0.000469	CcSEcCtD
Metoprolol—Pain—Travoprost—glaucoma	3.42e-05	0.000467	CcSEcCtD
Metoprolol—Constipation—Travoprost—glaucoma	3.42e-05	0.000467	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Brinzolamide—glaucoma	3.41e-05	0.000465	CcSEcCtD
Metoprolol—Paraesthesia—Pilocarpine—glaucoma	3.41e-05	0.000465	CcSEcCtD
Metoprolol—Asthenia—Bimatoprost—glaucoma	3.41e-05	0.000465	CcSEcCtD
Metoprolol—Fatigue—Brinzolamide—glaucoma	3.41e-05	0.000465	CcSEcCtD
Metoprolol—Dyspnoea—Pilocarpine—glaucoma	3.39e-05	0.000462	CcSEcCtD
Metoprolol—Pain—Brinzolamide—glaucoma	3.38e-05	0.000461	CcSEcCtD
Metoprolol—Somnolence—Pilocarpine—glaucoma	3.38e-05	0.000461	CcSEcCtD
Metoprolol—Depression—Timolol—glaucoma	3.37e-05	0.00046	CcSEcCtD
Metoprolol—Angiopathy—Betaxolol—glaucoma	3.37e-05	0.00046	CcSEcCtD
Metoprolol—Pruritus—Bimatoprost—glaucoma	3.36e-05	0.000459	CcSEcCtD
Metoprolol—Immune system disorder—Betaxolol—glaucoma	3.36e-05	0.000458	CcSEcCtD
Metoprolol—Diarrhoea—Apraclonidine—glaucoma	3.35e-05	0.000458	CcSEcCtD
Metoprolol—ADRB1—Endothelin Pathways—EDN1—glaucoma	3.35e-05	0.0146	CbGpPWpGaD
Metoprolol—Mediastinal disorder—Betaxolol—glaucoma	3.35e-05	0.000457	CcSEcCtD
Metoprolol—Dyspepsia—Pilocarpine—glaucoma	3.34e-05	0.000456	CcSEcCtD
Metoprolol—Syncope—Clonidine—glaucoma	3.33e-05	0.000455	CcSEcCtD
Metoprolol—Arrhythmia—Betaxolol—glaucoma	3.32e-05	0.000453	CcSEcCtD
Metoprolol—Feeling abnormal—Dorzolamide—glaucoma	3.31e-05	0.000452	CcSEcCtD
Metoprolol—Feeling abnormal—Travoprost—glaucoma	3.3e-05	0.00045	CcSEcCtD
Metoprolol—Conjunctivitis—Timolol—glaucoma	3.29e-05	0.000449	CcSEcCtD
Metoprolol—Gastrointestinal pain—Dorzolamide—glaucoma	3.29e-05	0.000448	CcSEcCtD
Metoprolol—Alopecia—Betaxolol—glaucoma	3.28e-05	0.000448	CcSEcCtD
Metoprolol—Palpitations—Clonidine—glaucoma	3.28e-05	0.000448	CcSEcCtD
Metoprolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	3.28e-05	0.0143	CbGpPWpGaD
Metoprolol—Gastrointestinal disorder—Pilocarpine—glaucoma	3.28e-05	0.000447	CcSEcCtD
Metoprolol—Gastrointestinal pain—Travoprost—glaucoma	3.27e-05	0.000446	CcSEcCtD
Metoprolol—Loss of consciousness—Clonidine—glaucoma	3.27e-05	0.000446	CcSEcCtD
Metoprolol—Feeling abnormal—Brinzolamide—glaucoma	3.26e-05	0.000444	CcSEcCtD
Metoprolol—Mental disorder—Betaxolol—glaucoma	3.26e-05	0.000444	CcSEcCtD
Metoprolol—Constipation—Pilocarpine—glaucoma	3.25e-05	0.000443	CcSEcCtD
Metoprolol—Pain—Pilocarpine—glaucoma	3.25e-05	0.000443	CcSEcCtD
Metoprolol—Sweating—Timolol—glaucoma	3.24e-05	0.000442	CcSEcCtD
Metoprolol—Dizziness—Apraclonidine—glaucoma	3.24e-05	0.000442	CcSEcCtD
Metoprolol—Urticaria—Dorzolamide—glaucoma	3.19e-05	0.000436	CcSEcCtD
Metoprolol—Body temperature increased—Dorzolamide—glaucoma	3.18e-05	0.000434	CcSEcCtD
Metoprolol—Abdominal pain—Dorzolamide—glaucoma	3.18e-05	0.000434	CcSEcCtD
Metoprolol—Tension—Betaxolol—glaucoma	3.17e-05	0.000433	CcSEcCtD
Metoprolol—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	3.17e-05	0.0138	CbGpPWpGaD
Metoprolol—Dysgeusia—Betaxolol—glaucoma	3.17e-05	0.000432	CcSEcCtD
Metoprolol—Chest pain—Clonidine—glaucoma	3.16e-05	0.000432	CcSEcCtD
Metoprolol—Arthralgia—Clonidine—glaucoma	3.16e-05	0.000432	CcSEcCtD
Metoprolol—Abdominal pain—Travoprost—glaucoma	3.16e-05	0.000432	CcSEcCtD
Metoprolol—Agranulocytosis—Timolol—glaucoma	3.16e-05	0.000431	CcSEcCtD
Metoprolol—Anxiety—Clonidine—glaucoma	3.15e-05	0.00043	CcSEcCtD
Metoprolol—Asthenia—Acetazolamide—glaucoma	3.15e-05	0.000429	CcSEcCtD
Metoprolol—Dizziness—Bimatoprost—glaucoma	3.14e-05	0.000429	CcSEcCtD
Metoprolol—Nervousness—Betaxolol—glaucoma	3.14e-05	0.000429	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	3.14e-05	0.000429	CcSEcCtD
Metoprolol—Urticaria—Brinzolamide—glaucoma	3.14e-05	0.000428	CcSEcCtD
Metoprolol—Feeling abnormal—Pilocarpine—glaucoma	3.13e-05	0.000427	CcSEcCtD
Metoprolol—Vomiting—Apraclonidine—glaucoma	3.12e-05	0.000425	CcSEcCtD
Metoprolol—Muscle spasms—Betaxolol—glaucoma	3.11e-05	0.000424	CcSEcCtD
Metoprolol—Gastrointestinal pain—Pilocarpine—glaucoma	3.11e-05	0.000424	CcSEcCtD
Metoprolol—Hypersensitivity—Brimonidine—glaucoma	3.1e-05	0.000423	CcSEcCtD
Metoprolol—Dry mouth—Clonidine—glaucoma	3.09e-05	0.000422	CcSEcCtD
Metoprolol—Bradycardia—Timolol—glaucoma	3.09e-05	0.000422	CcSEcCtD
Metoprolol—Dermatitis—Apraclonidine—glaucoma	3.09e-05	0.000421	CcSEcCtD
Metoprolol—Headache—Apraclonidine—glaucoma	3.07e-05	0.000419	CcSEcCtD
Metoprolol—Confusional state—Clonidine—glaucoma	3.06e-05	0.000417	CcSEcCtD
Metoprolol—Vision blurred—Betaxolol—glaucoma	3.05e-05	0.000416	CcSEcCtD
Metoprolol—Rhinitis—Timolol—glaucoma	3.04e-05	0.000415	CcSEcCtD
Metoprolol—Oedema—Clonidine—glaucoma	3.03e-05	0.000414	CcSEcCtD
Metoprolol—ADRB1—Melatonin metabolism and effects—APOE—glaucoma	3.02e-05	0.0132	CbGpPWpGaD
Metoprolol—Hallucination—Timolol—glaucoma	3.02e-05	0.000412	CcSEcCtD
Metoprolol—Asthenia—Brimonidine—glaucoma	3.02e-05	0.000412	CcSEcCtD
Metoprolol—Body temperature increased—Pilocarpine—glaucoma	3e-05	0.00041	CcSEcCtD
Metoprolol—Abdominal pain—Pilocarpine—glaucoma	3e-05	0.00041	CcSEcCtD
Metoprolol—Diarrhoea—Acetazolamide—glaucoma	3e-05	0.000409	CcSEcCtD
Metoprolol—Rash—Bimatoprost—glaucoma	3e-05	0.000409	CcSEcCtD
Metoprolol—Dermatitis—Bimatoprost—glaucoma	2.99e-05	0.000409	CcSEcCtD
Metoprolol—Oedema peripheral—Timolol—glaucoma	2.99e-05	0.000408	CcSEcCtD
Metoprolol—Shock—Clonidine—glaucoma	2.98e-05	0.000407	CcSEcCtD
Metoprolol—Connective tissue disorder—Timolol—glaucoma	2.98e-05	0.000407	CcSEcCtD
Metoprolol—Pruritus—Brimonidine—glaucoma	2.98e-05	0.000406	CcSEcCtD
Metoprolol—Headache—Bimatoprost—glaucoma	2.98e-05	0.000406	CcSEcCtD
Metoprolol—Nervous system disorder—Clonidine—glaucoma	2.97e-05	0.000406	CcSEcCtD
Metoprolol—Thrombocytopenia—Clonidine—glaucoma	2.97e-05	0.000405	CcSEcCtD
Metoprolol—Hypersensitivity—Dorzolamide—glaucoma	2.96e-05	0.000404	CcSEcCtD
Metoprolol—Tachycardia—Clonidine—glaucoma	2.96e-05	0.000404	CcSEcCtD
Metoprolol—Hypersensitivity—Travoprost—glaucoma	2.95e-05	0.000402	CcSEcCtD
Metoprolol—Skin disorder—Clonidine—glaucoma	2.95e-05	0.000402	CcSEcCtD
Metoprolol—Hyperhidrosis—Clonidine—glaucoma	2.93e-05	0.0004	CcSEcCtD
Metoprolol—Visual impairment—Timolol—glaucoma	2.93e-05	0.000399	CcSEcCtD
Metoprolol—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	2.92e-05	0.0127	CbGpPWpGaD
Metoprolol—Nausea—Apraclonidine—glaucoma	2.91e-05	0.000397	CcSEcCtD
Metoprolol—Hypersensitivity—Brinzolamide—glaucoma	2.91e-05	0.000397	CcSEcCtD
Metoprolol—Vertigo—Betaxolol—glaucoma	2.91e-05	0.000397	CcSEcCtD
Metoprolol—Syncope—Betaxolol—glaucoma	2.9e-05	0.000396	CcSEcCtD
Metoprolol—Dizziness—Acetazolamide—glaucoma	2.9e-05	0.000396	CcSEcCtD
Metoprolol—Asthenia—Dorzolamide—glaucoma	2.88e-05	0.000393	CcSEcCtD
Metoprolol—Asthenia—Travoprost—glaucoma	2.87e-05	0.000392	CcSEcCtD
Metoprolol—Palpitations—Betaxolol—glaucoma	2.86e-05	0.00039	CcSEcCtD
Metoprolol—Pruritus—Dorzolamide—glaucoma	2.84e-05	0.000388	CcSEcCtD
Metoprolol—Loss of consciousness—Betaxolol—glaucoma	2.84e-05	0.000388	CcSEcCtD
Metoprolol—Eye disorder—Timolol—glaucoma	2.84e-05	0.000387	CcSEcCtD
Metoprolol—Asthenia—Brinzolamide—glaucoma	2.83e-05	0.000387	CcSEcCtD
Metoprolol—Hypotension—Clonidine—glaucoma	2.83e-05	0.000387	CcSEcCtD
Metoprolol—Pruritus—Travoprost—glaucoma	2.83e-05	0.000386	CcSEcCtD
Metoprolol—Tinnitus—Timolol—glaucoma	2.83e-05	0.000386	CcSEcCtD
Metoprolol—Nausea—Bimatoprost—glaucoma	2.82e-05	0.000385	CcSEcCtD
Metoprolol—Cardiac disorder—Timolol—glaucoma	2.82e-05	0.000384	CcSEcCtD
Metoprolol—Hypersensitivity—Pilocarpine—glaucoma	2.8e-05	0.000382	CcSEcCtD
Metoprolol—Pruritus—Brinzolamide—glaucoma	2.8e-05	0.000381	CcSEcCtD
Metoprolol—Vomiting—Acetazolamide—glaucoma	2.79e-05	0.00038	CcSEcCtD
Metoprolol—Dizziness—Brimonidine—glaucoma	2.78e-05	0.00038	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Clonidine—glaucoma	2.76e-05	0.000377	CcSEcCtD
Metoprolol—Angiopathy—Timolol—glaucoma	2.75e-05	0.000376	CcSEcCtD
Metoprolol—Arthralgia—Betaxolol—glaucoma	2.75e-05	0.000376	CcSEcCtD
Metoprolol—Chest pain—Betaxolol—glaucoma	2.75e-05	0.000376	CcSEcCtD
Metoprolol—Diarrhoea—Dorzolamide—glaucoma	2.75e-05	0.000375	CcSEcCtD
Metoprolol—Headache—Acetazolamide—glaucoma	2.75e-05	0.000375	CcSEcCtD
Metoprolol—Anxiety—Betaxolol—glaucoma	2.74e-05	0.000375	CcSEcCtD
Metoprolol—Insomnia—Clonidine—glaucoma	2.74e-05	0.000374	CcSEcCtD
Metoprolol—Immune system disorder—Timolol—glaucoma	2.74e-05	0.000374	CcSEcCtD
Metoprolol—Diarrhoea—Travoprost—glaucoma	2.74e-05	0.000374	CcSEcCtD
Metoprolol—Mediastinal disorder—Timolol—glaucoma	2.74e-05	0.000373	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	2.74e-05	0.000373	CcSEcCtD
Metoprolol—Asthenia—Pilocarpine—glaucoma	2.72e-05	0.000372	CcSEcCtD
Metoprolol—Paraesthesia—Clonidine—glaucoma	2.72e-05	0.000372	CcSEcCtD
Metoprolol—Arrhythmia—Timolol—glaucoma	2.71e-05	0.00037	CcSEcCtD
Metoprolol—Dyspnoea—Clonidine—glaucoma	2.7e-05	0.000369	CcSEcCtD
Metoprolol—Diarrhoea—Brinzolamide—glaucoma	2.7e-05	0.000369	CcSEcCtD
Metoprolol—Somnolence—Clonidine—glaucoma	2.7e-05	0.000368	CcSEcCtD
Metoprolol—Dry mouth—Betaxolol—glaucoma	2.69e-05	0.000368	CcSEcCtD
Metoprolol—Pruritus—Pilocarpine—glaucoma	2.69e-05	0.000367	CcSEcCtD
Metoprolol—Alopecia—Timolol—glaucoma	2.68e-05	0.000366	CcSEcCtD
Metoprolol—Confusional state—Betaxolol—glaucoma	2.66e-05	0.000363	CcSEcCtD
Metoprolol—Mental disorder—Timolol—glaucoma	2.66e-05	0.000363	CcSEcCtD
Metoprolol—Dizziness—Dorzolamide—glaucoma	2.66e-05	0.000363	CcSEcCtD
Metoprolol—Rash—Brimonidine—glaucoma	2.65e-05	0.000362	CcSEcCtD
Metoprolol—Dermatitis—Brimonidine—glaucoma	2.65e-05	0.000362	CcSEcCtD
Metoprolol—Dizziness—Travoprost—glaucoma	2.65e-05	0.000361	CcSEcCtD
Metoprolol—Oedema—Betaxolol—glaucoma	2.64e-05	0.00036	CcSEcCtD
Metoprolol—Headache—Brimonidine—glaucoma	2.64e-05	0.00036	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Clonidine—glaucoma	2.62e-05	0.000357	CcSEcCtD
Metoprolol—Fatigue—Clonidine—glaucoma	2.61e-05	0.000357	CcSEcCtD
Metoprolol—Dizziness—Brinzolamide—glaucoma	2.61e-05	0.000357	CcSEcCtD
Metoprolol—Nausea—Acetazolamide—glaucoma	2.6e-05	0.000355	CcSEcCtD
Metoprolol—Diarrhoea—Pilocarpine—glaucoma	2.6e-05	0.000355	CcSEcCtD
Metoprolol—Shock—Betaxolol—glaucoma	2.6e-05	0.000354	CcSEcCtD
Metoprolol—Tension—Timolol—glaucoma	2.59e-05	0.000354	CcSEcCtD
Metoprolol—Constipation—Clonidine—glaucoma	2.59e-05	0.000354	CcSEcCtD
Metoprolol—Pain—Clonidine—glaucoma	2.59e-05	0.000354	CcSEcCtD
Metoprolol—Nervous system disorder—Betaxolol—glaucoma	2.59e-05	0.000353	CcSEcCtD
Metoprolol—Dysgeusia—Timolol—glaucoma	2.59e-05	0.000353	CcSEcCtD
Metoprolol—Thrombocytopenia—Betaxolol—glaucoma	2.58e-05	0.000353	CcSEcCtD
Metoprolol—Tachycardia—Betaxolol—glaucoma	2.58e-05	0.000352	CcSEcCtD
Metoprolol—Nervousness—Timolol—glaucoma	2.57e-05	0.00035	CcSEcCtD
Metoprolol—Skin disorder—Betaxolol—glaucoma	2.56e-05	0.00035	CcSEcCtD
Metoprolol—Vomiting—Dorzolamide—glaucoma	2.56e-05	0.000349	CcSEcCtD
Metoprolol—Hyperhidrosis—Betaxolol—glaucoma	2.55e-05	0.000348	CcSEcCtD
Metoprolol—Rash—Dorzolamide—glaucoma	2.53e-05	0.000346	CcSEcCtD
Metoprolol—Dermatitis—Dorzolamide—glaucoma	2.53e-05	0.000345	CcSEcCtD
Metoprolol—Rash—Travoprost—glaucoma	2.52e-05	0.000344	CcSEcCtD
Metoprolol—Dermatitis—Travoprost—glaucoma	2.52e-05	0.000344	CcSEcCtD
Metoprolol—Headache—Dorzolamide—glaucoma	2.52e-05	0.000344	CcSEcCtD
Metoprolol—Vomiting—Brinzolamide—glaucoma	2.51e-05	0.000343	CcSEcCtD
Metoprolol—Dizziness—Pilocarpine—glaucoma	2.51e-05	0.000343	CcSEcCtD
Metoprolol—Headache—Travoprost—glaucoma	2.51e-05	0.000342	CcSEcCtD
Metoprolol—Nausea—Brimonidine—glaucoma	2.5e-05	0.000341	CcSEcCtD
Metoprolol—Feeling abnormal—Clonidine—glaucoma	2.5e-05	0.000341	CcSEcCtD
Metoprolol—Rash—Brinzolamide—glaucoma	2.49e-05	0.00034	CcSEcCtD
Metoprolol—Vision blurred—Timolol—glaucoma	2.49e-05	0.00034	CcSEcCtD
Metoprolol—Dermatitis—Brinzolamide—glaucoma	2.49e-05	0.00034	CcSEcCtD
Metoprolol—Gastrointestinal pain—Clonidine—glaucoma	2.48e-05	0.000338	CcSEcCtD
Metoprolol—Headache—Brinzolamide—glaucoma	2.48e-05	0.000338	CcSEcCtD
Metoprolol—Hypotension—Betaxolol—glaucoma	2.47e-05	0.000337	CcSEcCtD
Metoprolol—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	2.45e-05	0.0107	CbGpPWpGaD
Metoprolol—Vomiting—Pilocarpine—glaucoma	2.41e-05	0.000329	CcSEcCtD
Metoprolol—Urticaria—Clonidine—glaucoma	2.41e-05	0.000329	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Betaxolol—glaucoma	2.41e-05	0.000328	CcSEcCtD
Metoprolol—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	2.4e-05	0.0105	CbGpPWpGaD
Metoprolol—Abdominal pain—Clonidine—glaucoma	2.4e-05	0.000327	CcSEcCtD
Metoprolol—Body temperature increased—Clonidine—glaucoma	2.4e-05	0.000327	CcSEcCtD
Metoprolol—Rash—Pilocarpine—glaucoma	2.39e-05	0.000327	CcSEcCtD
Metoprolol—Dermatitis—Pilocarpine—glaucoma	2.39e-05	0.000326	CcSEcCtD
Metoprolol—Insomnia—Betaxolol—glaucoma	2.39e-05	0.000326	CcSEcCtD
Metoprolol—Nausea—Dorzolamide—glaucoma	2.39e-05	0.000326	CcSEcCtD
Metoprolol—Headache—Pilocarpine—glaucoma	2.38e-05	0.000325	CcSEcCtD
Metoprolol—Nausea—Travoprost—glaucoma	2.38e-05	0.000324	CcSEcCtD
Metoprolol—Vertigo—Timolol—glaucoma	2.37e-05	0.000324	CcSEcCtD
Metoprolol—Paraesthesia—Betaxolol—glaucoma	2.37e-05	0.000323	CcSEcCtD
Metoprolol—Syncope—Timolol—glaucoma	2.37e-05	0.000323	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	2.36e-05	0.0103	CbGpPWpGaD
Metoprolol—Dyspnoea—Betaxolol—glaucoma	2.35e-05	0.000321	CcSEcCtD
Metoprolol—Nausea—Brinzolamide—glaucoma	2.35e-05	0.00032	CcSEcCtD
Metoprolol—Palpitations—Timolol—glaucoma	2.34e-05	0.000319	CcSEcCtD
Metoprolol—Dyspepsia—Betaxolol—glaucoma	2.32e-05	0.000317	CcSEcCtD
Metoprolol—Loss of consciousness—Timolol—glaucoma	2.32e-05	0.000317	CcSEcCtD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	2.31e-05	0.0101	CbGpPWpGaD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	2.31e-05	0.0101	CbGpPWpGaD
Metoprolol—Hypertension—Timolol—glaucoma	2.28e-05	0.000311	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Betaxolol—glaucoma	2.28e-05	0.000311	CcSEcCtD
Metoprolol—Fatigue—Betaxolol—glaucoma	2.28e-05	0.000311	CcSEcCtD
Metoprolol—Constipation—Betaxolol—glaucoma	2.26e-05	0.000308	CcSEcCtD
Metoprolol—Pain—Betaxolol—glaucoma	2.26e-05	0.000308	CcSEcCtD
Metoprolol—Nausea—Pilocarpine—glaucoma	2.26e-05	0.000308	CcSEcCtD
Metoprolol—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	2.25e-05	0.00981	CbGpPWpGaD
Metoprolol—Arthralgia—Timolol—glaucoma	2.25e-05	0.000307	CcSEcCtD
Metoprolol—Chest pain—Timolol—glaucoma	2.25e-05	0.000307	CcSEcCtD
Metoprolol—Anxiety—Timolol—glaucoma	2.24e-05	0.000306	CcSEcCtD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC4A4—glaucoma	2.24e-05	0.00974	CbGpPWpGaD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	2.23e-05	0.000305	CcSEcCtD
Metoprolol—Hypersensitivity—Clonidine—glaucoma	2.23e-05	0.000305	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Other—SMO—glaucoma	2.21e-05	0.00963	CbGpPWpGaD
Metoprolol—Dry mouth—Timolol—glaucoma	2.2e-05	0.0003	CcSEcCtD
Metoprolol—Asthenia—Clonidine—glaucoma	2.18e-05	0.000297	CcSEcCtD
Metoprolol—Feeling abnormal—Betaxolol—glaucoma	2.18e-05	0.000297	CcSEcCtD
Metoprolol—Confusional state—Timolol—glaucoma	2.17e-05	0.000297	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	2.16e-05	0.00942	CbGpPWpGaD
Metoprolol—Oedema—Timolol—glaucoma	2.16e-05	0.000294	CcSEcCtD
Metoprolol—Pruritus—Clonidine—glaucoma	2.15e-05	0.000293	CcSEcCtD
Metoprolol—Shock—Timolol—glaucoma	2.12e-05	0.00029	CcSEcCtD
Metoprolol—Nervous system disorder—Timolol—glaucoma	2.12e-05	0.000289	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	2.11e-05	0.00921	CbGpPWpGaD
Metoprolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	2.1e-05	0.00917	CbGpPWpGaD
Metoprolol—Urticaria—Betaxolol—glaucoma	2.1e-05	0.000286	CcSEcCtD
Metoprolol—Skin disorder—Timolol—glaucoma	2.09e-05	0.000286	CcSEcCtD
Metoprolol—Body temperature increased—Betaxolol—glaucoma	2.09e-05	0.000285	CcSEcCtD
Metoprolol—Hyperhidrosis—Timolol—glaucoma	2.08e-05	0.000285	CcSEcCtD
Metoprolol—Diarrhoea—Clonidine—glaucoma	2.07e-05	0.000283	CcSEcCtD
Metoprolol—ADRB1—Endothelin Pathways—NOS3—glaucoma	2.04e-05	0.0089	CbGpPWpGaD
Metoprolol—Hypotension—Timolol—glaucoma	2.02e-05	0.000275	CcSEcCtD
Metoprolol—Dizziness—Clonidine—glaucoma	2.01e-05	0.000274	CcSEcCtD
Metoprolol—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	1.98e-05	0.00863	CbGpPWpGaD
Metoprolol—Musculoskeletal discomfort—Timolol—glaucoma	1.96e-05	0.000268	CcSEcCtD
Metoprolol—Insomnia—Timolol—glaucoma	1.95e-05	0.000266	CcSEcCtD
Metoprolol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.95e-05	0.00848	CbGpPWpGaD
Metoprolol—Hypersensitivity—Betaxolol—glaucoma	1.95e-05	0.000265	CcSEcCtD
Metoprolol—Paraesthesia—Timolol—glaucoma	1.94e-05	0.000264	CcSEcCtD
Metoprolol—Vomiting—Clonidine—glaucoma	1.93e-05	0.000263	CcSEcCtD
Metoprolol—Dyspnoea—Timolol—glaucoma	1.92e-05	0.000262	CcSEcCtD
Metoprolol—Somnolence—Timolol—glaucoma	1.92e-05	0.000262	CcSEcCtD
Metoprolol—Rash—Clonidine—glaucoma	1.91e-05	0.000261	CcSEcCtD
Metoprolol—Dermatitis—Clonidine—glaucoma	1.91e-05	0.000261	CcSEcCtD
Metoprolol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	1.9e-05	0.0083	CbGpPWpGaD
Metoprolol—Headache—Clonidine—glaucoma	1.9e-05	0.000259	CcSEcCtD
Metoprolol—Dyspepsia—Timolol—glaucoma	1.9e-05	0.000259	CcSEcCtD
Metoprolol—Asthenia—Betaxolol—glaucoma	1.89e-05	0.000258	CcSEcCtD
Metoprolol—Pruritus—Betaxolol—glaucoma	1.87e-05	0.000255	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Timolol—glaucoma	1.86e-05	0.000254	CcSEcCtD
Metoprolol—Fatigue—Timolol—glaucoma	1.86e-05	0.000254	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.85e-05	0.00807	CbGpPWpGaD
Metoprolol—Pain—Timolol—glaucoma	1.84e-05	0.000252	CcSEcCtD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—SLC6A13—glaucoma	1.84e-05	0.00802	CbGpPWpGaD
Metoprolol—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	1.82e-05	0.00794	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	1.81e-05	0.00789	CbGpPWpGaD
Metoprolol—Diarrhoea—Betaxolol—glaucoma	1.81e-05	0.000246	CcSEcCtD
Metoprolol—Nausea—Clonidine—glaucoma	1.8e-05	0.000246	CcSEcCtD
Metoprolol—Feeling abnormal—Timolol—glaucoma	1.78e-05	0.000243	CcSEcCtD
Metoprolol—Gastrointestinal pain—Timolol—glaucoma	1.76e-05	0.000241	CcSEcCtD
Metoprolol—Dizziness—Betaxolol—glaucoma	1.75e-05	0.000238	CcSEcCtD
Metoprolol—Urticaria—Timolol—glaucoma	1.71e-05	0.000234	CcSEcCtD
Metoprolol—Abdominal pain—Timolol—glaucoma	1.7e-05	0.000233	CcSEcCtD
Metoprolol—Body temperature increased—Timolol—glaucoma	1.7e-05	0.000233	CcSEcCtD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—PEX19—glaucoma	1.68e-05	0.00733	CbGpPWpGaD
Metoprolol—Vomiting—Betaxolol—glaucoma	1.68e-05	0.000229	CcSEcCtD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	1.67e-05	0.00727	CbGpPWpGaD
Metoprolol—Rash—Betaxolol—glaucoma	1.66e-05	0.000227	CcSEcCtD
Metoprolol—Dermatitis—Betaxolol—glaucoma	1.66e-05	0.000227	CcSEcCtD
Metoprolol—Headache—Betaxolol—glaucoma	1.65e-05	0.000226	CcSEcCtD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	1.63e-05	0.00711	CbGpPWpGaD
Metoprolol—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	1.61e-05	0.00702	CbGpPWpGaD
Metoprolol—Hypersensitivity—Timolol—glaucoma	1.59e-05	0.000217	CcSEcCtD
Metoprolol—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	1.58e-05	0.0069	CbGpPWpGaD
Metoprolol—Nausea—Betaxolol—glaucoma	1.57e-05	0.000214	CcSEcCtD
Metoprolol—Asthenia—Timolol—glaucoma	1.55e-05	0.000211	CcSEcCtD
Metoprolol—Pruritus—Timolol—glaucoma	1.53e-05	0.000208	CcSEcCtD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC6A13—glaucoma	1.49e-05	0.0065	CbGpPWpGaD
Metoprolol—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	1.48e-05	0.00645	CbGpPWpGaD
Metoprolol—Diarrhoea—Timolol—glaucoma	1.48e-05	0.000201	CcSEcCtD
Metoprolol—Dizziness—Timolol—glaucoma	1.43e-05	0.000195	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—OPN4—glaucoma	1.41e-05	0.00614	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—SLC6A13—glaucoma	1.41e-05	0.00614	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—OPN4—glaucoma	1.38e-05	0.00601	CbGpPWpGaD
Metoprolol—Vomiting—Timolol—glaucoma	1.37e-05	0.000187	CcSEcCtD
Metoprolol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.37e-05	0.00596	CbGpPWpGaD
Metoprolol—Rash—Timolol—glaucoma	1.36e-05	0.000186	CcSEcCtD
Metoprolol—Dermatitis—Timolol—glaucoma	1.36e-05	0.000185	CcSEcCtD
Metoprolol—Headache—Timolol—glaucoma	1.35e-05	0.000184	CcSEcCtD
Metoprolol—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.35e-05	0.00589	CbGpPWpGaD
Metoprolol—SLC22A2—Transmission across Chemical Synapses—SLC6A1—glaucoma	1.35e-05	0.00587	CbGpPWpGaD
Metoprolol—Nausea—Timolol—glaucoma	1.28e-05	0.000175	CcSEcCtD
Metoprolol—ADRB1—GPCR ligand binding—PTGFR—glaucoma	1.27e-05	0.00553	CbGpPWpGaD
Metoprolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	1.26e-05	0.00548	CbGpPWpGaD
Metoprolol—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	1.24e-05	0.00541	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—PTGFR—glaucoma	1.24e-05	0.00541	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	1.14e-05	0.00495	CbGpPWpGaD
Metoprolol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.11e-05	0.00483	CbGpPWpGaD
Metoprolol—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	1.09e-05	0.00476	CbGpPWpGaD
Metoprolol—SLC22A2—Neuronal System—SLC6A1—glaucoma	1.03e-05	0.0045	CbGpPWpGaD
Metoprolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.02e-05	0.00445	CbGpPWpGaD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	1e-05	0.00436	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CA5A—glaucoma	9.26e-06	0.00404	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NARFL—glaucoma	9.26e-06	0.00404	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	9.19e-06	0.004	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—IL1A—glaucoma	8.62e-06	0.00376	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—OPN4—glaucoma	7.97e-06	0.00347	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—OPN4—glaucoma	7.8e-06	0.0034	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—FAS—glaucoma	7.68e-06	0.00335	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.58e-06	0.0033	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—C3—glaucoma	7.58e-06	0.0033	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—GSTT1—glaucoma	7.4e-06	0.00322	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—OPN4—glaucoma	7.24e-06	0.00315	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PTGFR—glaucoma	7.18e-06	0.00313	CbGpPWpGaD
Metoprolol—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	7.14e-06	0.00311	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—OPN4—glaucoma	7.08e-06	0.00308	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PTGFR—glaucoma	7.02e-06	0.00306	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—GSTT1—glaucoma	6.81e-06	0.00296	CbGpPWpGaD
Metoprolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	6.71e-06	0.00292	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PTGFR—glaucoma	6.52e-06	0.00284	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	6.49e-06	0.00283	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—SMO—glaucoma	6.4e-06	0.00279	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PTGFR—glaucoma	6.38e-06	0.00278	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—SMO—glaucoma	6.26e-06	0.00273	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	6.21e-06	0.0027	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—LRP12—glaucoma	6.17e-06	0.00269	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—LRP12—glaucoma	6.04e-06	0.00263	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—CYP1B1—glaucoma	5.9e-06	0.00257	CbGpPWpGaD
Metoprolol—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	5.81e-06	0.00253	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.55e-06	0.00242	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.54e-06	0.00242	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.51e-06	0.0024	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	5.42e-06	0.00236	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—CYP1B1—glaucoma	5.42e-06	0.00236	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	5.35e-06	0.00233	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CA5A—glaucoma	5.19e-06	0.00226	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NARFL—glaucoma	5.19e-06	0.00226	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NARFL—glaucoma	5.06e-06	0.0022	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CA5A—glaucoma	5.06e-06	0.0022	CbGpPWpGaD
Metoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.84e-06	0.00211	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.84e-06	0.00211	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CA5A—glaucoma	4.77e-06	0.00208	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NARFL—glaucoma	4.77e-06	0.00208	CbGpPWpGaD
Metoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	4.74e-06	0.00206	CbGpPWpGaD
Metoprolol—CYP2C19—Biological oxidations—GSTM1—glaucoma	4.71e-06	0.00205	CbGpPWpGaD
Metoprolol—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	4.65e-06	0.00202	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CA1—glaucoma	4.52e-06	0.00197	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	4.46e-06	0.00194	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	4.43e-06	0.00193	CbGpPWpGaD
Metoprolol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	4.4e-06	0.00191	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CTSA—glaucoma	4.38e-06	0.00191	CbGpPWpGaD
Metoprolol—CYP2D6—Biological oxidations—GSTM1—glaucoma	4.33e-06	0.00189	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—OPN4—glaucoma	4.28e-06	0.00186	CbGpPWpGaD
Metoprolol—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	4.28e-06	0.00186	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—EDN1—glaucoma	4.22e-06	0.00184	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—OPN4—glaucoma	4.18e-06	0.00182	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	4.14e-06	0.0018	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CA2—glaucoma	4.14e-06	0.0018	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—EDN1—glaucoma	4.13e-06	0.0018	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HEYL—glaucoma	3.98e-06	0.00173	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HEYL—glaucoma	3.89e-06	0.00169	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTGFR—glaucoma	3.85e-06	0.00168	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—VEGFA—glaucoma	3.81e-06	0.00166	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.79e-06	0.00165	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTGFR—glaucoma	3.77e-06	0.00164	CbGpPWpGaD
Metoprolol—ADRB1—GPCR ligand binding—C3—glaucoma	3.69e-06	0.00161	CbGpPWpGaD
Metoprolol—ADRB2—GPCR ligand binding—C3—glaucoma	3.61e-06	0.00157	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—SMO—glaucoma	3.29e-06	0.00143	CbGpPWpGaD
Metoprolol—ABCB1—Allograft Rejection—TNF—glaucoma	3.26e-06	0.00142	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	3.24e-06	0.00141	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—SMO—glaucoma	3.22e-06	0.0014	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.03e-06	0.00132	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RPTOR—glaucoma	3.01e-06	0.00131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RPTOR—glaucoma	2.95e-06	0.00128	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NCK2—glaucoma	2.92e-06	0.00127	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—TXN—glaucoma	2.92e-06	0.00127	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NCK2—glaucoma	2.85e-06	0.00124	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CA1—glaucoma	2.53e-06	0.0011	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HDAC9—glaucoma	2.48e-06	0.00108	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CA1—glaucoma	2.47e-06	0.00108	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CTSA—glaucoma	2.45e-06	0.00107	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HDAC9—glaucoma	2.43e-06	0.00106	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CTSA—glaucoma	2.39e-06	0.00104	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—EDN1—glaucoma	2.39e-06	0.00104	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.38e-06	0.00104	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—EDN1—glaucoma	2.33e-06	0.00102	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CA1—glaucoma	2.33e-06	0.00101	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CA2—glaucoma	2.32e-06	0.00101	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.26e-06	0.000986	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.26e-06	0.000986	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTT1—glaucoma	2.26e-06	0.000985	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CA2—glaucoma	2.26e-06	0.000985	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	2.26e-06	0.000984	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CTSA—glaucoma	2.26e-06	0.000983	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—EDN1—glaucoma	2.17e-06	0.000944	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CA2—glaucoma	2.13e-06	0.000928	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—EDN1—glaucoma	2.12e-06	0.000923	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—C3—glaucoma	2.08e-06	0.000908	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—C3—glaucoma	2.04e-06	0.000888	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SMO—glaucoma	1.94e-06	0.000846	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SMO—glaucoma	1.9e-06	0.000827	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—C3—glaucoma	1.89e-06	0.000825	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.88e-06	0.000818	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—C3—glaucoma	1.85e-06	0.000807	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP1B1—glaucoma	1.8e-06	0.000785	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ABCA1—glaucoma	1.8e-06	0.000785	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NTRK2—glaucoma	1.78e-06	0.000774	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NTRK2—glaucoma	1.74e-06	0.000757	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TXN—glaucoma	1.63e-06	0.000711	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.61e-06	0.000701	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TXN—glaucoma	1.59e-06	0.000694	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NGFR—glaucoma	1.52e-06	0.000664	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TXN—glaucoma	1.5e-06	0.000654	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NGFR—glaucoma	1.49e-06	0.000649	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.49e-06	0.000649	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.48e-06	0.000643	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NTRK1—glaucoma	1.45e-06	0.000631	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GSTM1—glaucoma	1.44e-06	0.000627	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.42e-06	0.000618	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NTRK1—glaucoma	1.42e-06	0.000617	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN2B—glaucoma	1.33e-06	0.000581	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN2B—glaucoma	1.3e-06	0.000568	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—EDN1—glaucoma	1.28e-06	0.000558	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—MTHFR—glaucoma	1.27e-06	0.000554	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTT1—glaucoma	1.27e-06	0.000551	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—EDN1—glaucoma	1.25e-06	0.000545	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTT1—glaucoma	1.23e-06	0.000538	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—glaucoma	1.18e-06	0.000516	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NGF—glaucoma	1.18e-06	0.000512	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CAV1—glaucoma	1.17e-06	0.000511	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTT1—glaucoma	1.16e-06	0.000507	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NGF—glaucoma	1.15e-06	0.000501	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—C3—glaucoma	1.12e-06	0.000487	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—C3—glaucoma	1.09e-06	0.000477	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—glaucoma	1.04e-06	0.000453	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CAV1—glaucoma	1.03e-06	0.000449	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.02e-06	0.000444	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—glaucoma	1.02e-06	0.000444	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CAV1—glaucoma	1.01e-06	0.00044	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCA1—glaucoma	1.01e-06	0.000439	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP1B1—glaucoma	1.01e-06	0.000439	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP1B1—glaucoma	9.84e-07	0.000429	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ABCA1—glaucoma	9.84e-07	0.000429	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FN1—glaucoma	9.82e-07	0.000428	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—BAD—glaucoma	9.7e-07	0.000423	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FN1—glaucoma	9.6e-07	0.000418	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—BAD—glaucoma	9.49e-07	0.000413	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCA1—glaucoma	9.27e-07	0.000404	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP1B1—glaucoma	9.27e-07	0.000404	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—NOS3—glaucoma	8.88e-07	0.000387	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—glaucoma	8.12e-07	0.000354	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GSTM1—glaucoma	8.06e-07	0.000351	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GSTM1—glaucoma	7.87e-07	0.000343	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NOS3—glaucoma	7.8e-07	0.00034	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NOS3—glaucoma	7.63e-07	0.000332	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GSTM1—glaucoma	7.41e-07	0.000323	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—MTHFR—glaucoma	7.12e-07	0.00031	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—MTHFR—glaucoma	6.95e-07	0.000303	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDKN1B—glaucoma	6.76e-07	0.000294	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—glaucoma	6.63e-07	0.000289	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDKN1B—glaucoma	6.61e-07	0.000288	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAV1—glaucoma	6.57e-07	0.000286	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—MTHFR—glaucoma	6.55e-07	0.000285	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—glaucoma	6.47e-07	0.000282	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAV1—glaucoma	6.41e-07	0.000279	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—glaucoma	6.26e-07	0.000273	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—glaucoma	6.12e-07	0.000267	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—glaucoma	6.1e-07	0.000266	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAV1—glaucoma	6.04e-07	0.000263	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—glaucoma	5.62e-07	0.000245	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—glaucoma	5.5e-07	0.000239	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—NOS3—glaucoma	4.97e-07	0.000216	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—NOS3—glaucoma	4.85e-07	0.000211	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NOS3—glaucoma	4.57e-07	0.000199	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—glaucoma	4.54e-07	0.000198	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—glaucoma	4.43e-07	0.000193	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TP53—glaucoma	4.25e-07	0.000185	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—glaucoma	4.18e-07	0.000182	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TP53—glaucoma	4.15e-07	0.000181	CbGpPWpGaD
